ArticleMedicine2020

Efficacy and safety of DPP-4 inhibitor in the treatment of patients with COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis.

Yan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.